01.11.2022 /
- 26.09.2023 / Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma
- 22.09.2023 / Starting up with highly promising immunotherapies
- 14.09.2023 / Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients
